101. Development of Clickable Monophosphoryl Lipid A Derivatives toward Semisynthetic Conjugates with Tumor-Associated Carbohydrate Antigens
- Author
-
Emiliano Bedini, Maria Michela Corsaro, Serena Traboni, Sabina Górska, Angela Casillo, Agnieszka Razim, Marcello Ziaco, Alfonso Iadonisi, Andrzej Gamian, Ziaco, Marcello, Górska, Sabina, Traboni, Serena, Razim, Agnieszka, Casillo, Angela, Iadonisi, Alfonso, Gamian, Andrzej, Corsaro, MARIA MICHELA, and Bedini, Emiliano
- Subjects
Azides ,Carbohydrate chemistry ,Monophosphoryl Lipid A ,010402 general chemistry ,Cancer Vaccines ,01 natural sciences ,Lipid A ,chemistry.chemical_compound ,Adjuvants, Immunologic ,Antigen ,Neoplasms ,Drug Discovery ,Escherichia coli ,Humans ,Antigens, Tumor-Associated, Carbohydrate ,Sulfhydryl Compounds ,010405 organic chemistry ,Immunogenicity ,0104 chemical sciences ,chemistry ,Biochemistry ,Alkynes ,Click chemistry ,Molecular Medicine ,Click Chemistry ,Azide ,Conjugate - Abstract
A semisynthetic strategy to obtain monophosphoryl lipid A derivatives equipped with clickable (azide, alkyne, double bond, or thiol precursor) moieties, starting from the native lipid A isolated from Escherichia coli, is presented. These lipid A derivatives can be conjugated with other interesting biomolecules, such as tumor-associated carbohydrate antigens (TACAs). In this way, the immunostimulant activity of monophosphoryl lipid A can significantly improve the immunogenicity of TACAs, thus opening access to potential self-adjuvant anticancer vaccine candidates. A monophosphoryl lipid A−Thomson-Friedenreich (TF) antigen conjugate was obtained to demonstrate the feasibility of this methodology, which stands as a valuable, rapid, and scalable alternative to the highly complex approaches of total synthesis recently reported to the same aim. A preliminary evaluation of the immunological activity of this conjugate as well as of other semisynthetic lipid A derivatives was also reported.
- Published
- 2017
- Full Text
- View/download PDF